The role of cholesterol and glycosylphosphatidylinositol-anchored proteins of erythrocyte rafts in regulating raft protein content and malarial infection.
Human erythrocytes are terminally differentiated, nonendocytic cells that lack all intracellular organelles. Here we show that their plasma membranes contain detergent-resistant membrane rafts that constitute a small fraction (4%) of the total membrane protein, with a complex mixture of proteins that differentially associate with rafts. Depletion of raft-cholesterol abrogates association of all proteins with no significant effect on cholesterol:protein ratios in the rest of the membrane, lipid asymmetry, deformability, or transport properties of the bilayer, indicating that cholesterol is critical for protein assembly into rafts and suggesting that rafts have little influence on several erythrocyte functions. Erythrocytes from patients with paroxysmal nocturnal hemoglobinuria, which lack glycosylphosphatidylinositol-anchored proteins, show significant elevation in raft-cholesterol but no increase in raft protein association, suggesting that raft assembly does not require glycosylphosphatidylinositol-anchored proteins, raft proteins do not bind directly to cholesterol, and only threshold levels of raft-cholesterol are critical for protein recruitment. Loss of glycosylphosphatidylinositol-anchored proteins had no effect on erythrocytic infection by malarial parasite or movement of raft markers into the parasite's vacuole. However, infection is blocked following raft-cholesterol disruption, suggesting that erythrocyte rafts can be functionally exploited and providing the first evidence for the involvement of host rafts in an apicomplexan infection.
Samuel
B U
BU
Department of Pathology, Northwestern University, Chicago, Illinois 60611, USA.
Mohandas
N
N
Harrison
T
T
McManus
H
H
Rosse
W
W
Reid
M
M
Haldar
K
K
D000818:Animals; D018957:CD59 Antigens / Q000097:blood; D002784:Cholesterol / Q000097:blood*; D003505:Cyclodextrins / Q000494:pharmacology; D004907:Erythrocyte Deformability; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000502:physiology*; D004912:Erythrocytes / Q000187:drug effects / Q000469:parasitology* / Q000502:physiology*; D017261:Glycosylphosphatidylinositols / Q000097:blood*; D006457:Hemoglobinuria, Paroxysmal / Q000097:blood; D006801:Humans; D066298:In Vitro Techniques; D008051:Lipid Bilayers; D016778:Malaria, Falciparum / Q000097:blood*; D021962:Membrane Microdomains / Q000502:physiology* / Q000648:ultrastructure; D008565:Membrane Proteins / Q000097:blood*; D010963:Plasmodium falciparum / Q000254:growth & development / Q000472:pathogenicity / Q000502:physiology*; D012016:Reference Values; D014617:Vacuoles / Q000502:physiology / Q000648:ultrastructure; D047392:beta-Cyclodextrins
D018957:CD59 Antigens; D003505:Cyclodextrins; D017261:Glycosylphosphatidylinositols; D008051:Lipid Bilayers; D008565:Membrane Proteins; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D002784:Cholesterol